Biogen (BIIB) Other Operating Expenses (2009 - 2026)
Biogen (BIIB) posted quarterly Other Operating Expenses of -$18.5 million for Q2 2026, up 62.01% year-over-year from -$11.4 million in Q2 2025, and up 6.09% quarter-over-quarter from -$19.7 million in Q1 2026.
Biogen (BIIB) Other Operating Expenses (2009 - 2026) Analysis & Trends
Biogen's Other Operating Expenses history runs 18 years deep, the most recent figure standing at -$18.5 million for Q2 2026.
- In Q2 2026, Other Operating Expenses rose 62.01% year-over-year to -$18.5 million; the TTM figure through Jun 2026 stood at $45.3 million (down 69.88% YoY), while the FY2025 annual figure was -$33.6 million, down 137.92% from the prior year.
- Other Operating Expenses for Q2 2026 stood at -$18.5 million, up from -$19.7 million in the prior quarter.
- The five-year high for Other Operating Expenses was $503.7 million in Q3 2022, with the low at -$300.0 million in Q3 2023.
- The 5-year median for Other Operating Expenses is -$19.1 million (2026), against an average of $38.6 million.
- Peak annual rise in Other Operating Expenses reached 344.61% in 2022, while the deepest fall reached 878.99% in 2022.
- Biogen's Other Operating Expenses stood at -$165.3 million in 2022, then surged by 250.15% to $248.2 million in 2023, then gained by 13.74% to $282.3 million in 2024, then tumbled by 58.34% to $117.6 million in 2025, then slumped by 115.73% to -$18.5 million in 2026.
- Business Quant data shows BIIB's Other Operating Expenses at -$18.5 million in Q2 2026, -$19.7 million in Q1 2026, and $117.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Biogen | 32.04 Bn | 30.76 Bn | 1.96 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -18.50 Mn |
| Mar 31, 2026 | -19.70 Mn |
| Dec 31, 2025 | 117.60 Mn |
| Sep 30, 2025 | -34.10 Mn |
| Jun 30, 2025 | -48.70 Mn |
| Mar 31, 2025 | -68.40 Mn |
| Dec 31, 2024 | 282.30 Mn |
| Sep 30, 2024 | -14.80 Mn |
| Jun 30, 2024 | 88.60 Mn |
| Mar 31, 2024 | -93.70 Mn |
| Dec 31, 2023 | 248.20 Mn |
| Sep 30, 2023 | -300.00 Mn |
| Jun 30, 2023 | 121.20 Mn |
| Mar 31, 2023 | -69.40 Mn |
| Dec 31, 2022 | -165.30 Mn |
| Sep 30, 2022 | 503.70 Mn |
| Jun 30, 2022 | 428.60 Mn |
| Mar 31, 2022 | -263.30 Mn |
| Dec 31, 2021 | 964.10 Mn |
| Sep 30, 2021 | -502.90 Mn |